Braden Parker
Fortune : 546 000 $ au 31/05/2026
Fortune : 546 000 $ au 31/05/2026
Braden Parker currently works at Savara, Inc., as Chief Commercial Officer from 2024.
Mr. Parker also formerly worked at PTC Therapeutics, Inc., as Vice President & General Manager from 2017 to 2020 and Orchard Therapeutics Plc, as Chief Commercial Officer from 2021 to 2024.
Mr. Parker received his undergraduate degree from the University of Notre Dame and Masters Business Admin degree from The Leonard N Stern School of Business.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SAVARA, INC. 0,05% | 12/12/2024 | 105 000 ( 0,05% ) | 546 000 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| SAVARA INC. | Corporate Officer/Principal | 24/09/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
| ORCHARD THERAPEUTICS PLC | Corporate Officer/Principal | 01/02/2024 |
| PTC THERAPEUTICS, INC. | Corporate Officer/Principal | 01/03/2020 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
PTC Therapeutics, Inc.
PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
University of Notre Dame
University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Leonard N Stern School of Business
The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Savara, Inc.
Savara, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals to treat respiratory diseases | Health Technology |
Orchard Therapeutics Plc
Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national